Androgen News and Research

RSS
UCSF project to explore mystery behind advanced prostate cancer

UCSF project to explore mystery behind advanced prostate cancer

PARP-1 plays a major role in controlling AR function in prostate cancer patients

PARP-1 plays a major role in controlling AR function in prostate cancer patients

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

Data from GTx's enobosarm Phase IIb study on cancer to be presented at SIOG meeting

Hormone and androgen receptor genes combined affect sperm motility

Hormone and androgen receptor genes combined affect sperm motility

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

Active Biotech, Ipsen announce new data on biomarkers from tasquinimod Phase II study in CRPC

September issue of JNCCN publishes two prostate cancer articles

September issue of JNCCN publishes two prostate cancer articles

First Edition: September 28, 2012

First Edition: September 28, 2012

Anti-androgen therapies may benefit bladder cancer patients

Anti-androgen therapies may benefit bladder cancer patients

Marijuana and testicular cancer: an interview with Victoria Cortessis

Marijuana and testicular cancer: an interview with Victoria Cortessis

Glucocorticoids can thwart androgen receptor activity and regulate fat storage

Glucocorticoids can thwart androgen receptor activity and regulate fat storage

Adolescent menstrual disorders linked to hyperandrogenemia

Adolescent menstrual disorders linked to hyperandrogenemia

Alendronate decreases BMD loss in prostate cancer

Alendronate decreases BMD loss in prostate cancer

Power of taxane-based chemotherapy drugs may be potentially underestimated

Power of taxane-based chemotherapy drugs may be potentially underestimated

Intermittent hormone therapy effective for prostate cancer patients

Intermittent hormone therapy effective for prostate cancer patients

Study finds sex differences in vision between men and women

Study finds sex differences in vision between men and women

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Survival rate for African-American men with prostate cancer now comparable to Caucasians

Survival rate for African-American men with prostate cancer now comparable to Caucasians

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide extends castration-resistant prostate cancer survival

Enzalutamide drug extends survival in people with advanced prostate cancer

Enzalutamide drug extends survival in people with advanced prostate cancer

Therapeutic breaks for prostate cancer patients

Therapeutic breaks for prostate cancer patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.